148 related articles for article (PubMed ID: 3099648)
1. [In vivo chemosensitivity test for UFT and FT-207. I--Subrenal capsule assay].
Nishiyama M; Niimi K; Yamaguchi M; Hirabayashi N; Nosoh Y; Tohge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):109-13. PubMed ID: 3099648
[TBL] [Abstract][Full Text] [Related]
2. [In vivo chemosensitivity test for UFT and FT-207. II. Chemosensitivity test on human tumor xenografts transplanted in nude mice].
Niimi K; Nishiyama M; Hirabayashi N; Yamaguchi M; Nosoh Y; Wang DC; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1281-5. PubMed ID: 3107479
[TBL] [Abstract][Full Text] [Related]
3. [Results of the UFT sensitivity test using human urogenital cancers transplanted subcutaneously and under the subrenal capsule of nude mice].
Murahashi I; Honda M; Mukae K; Hosoya Y; Takasaki E
Gan To Kagaku Ryoho; 1988 Feb; 15(2):231-5. PubMed ID: 3124766
[TBL] [Abstract][Full Text] [Related]
4. [Subrenal capsule assay of nude mice for testing the effectiveness of UFT for rat prostatic carcinoma (R3327)].
Uchida K; Hayashi T; Nishijima Y; Kasaya T; Akaza H; Koiso K; Nemoto R; Harada M
Gan To Kagaku Ryoho; 1993 Feb; 20(2):229-33. PubMed ID: 8434960
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study of UFT in prostatic carcinoma (DU-145) in nude mice].
Kagawa S; Takigawa H; Aga Y; Kurokawa K
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3408-12. PubMed ID: 3098182
[TBL] [Abstract][Full Text] [Related]
6. [A sensitivity test of UFT and FT-207 against human pulmonary cancer using nude mice].
Urabe N; Momiki S; Shiba M; Yamaguchi Y
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2224-8. PubMed ID: 3136694
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of prostatic carcinoma with UFT and leucovorin--basic study using SRCA].
Uchida K; Hayashi T; Shiga T; Hattori K; Nishijima Y; Kasaya S; Shimazui T; Akaza H; Koiso K; Nemoto R
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2633-7. PubMed ID: 7979424
[TBL] [Abstract][Full Text] [Related]
8. [Chemosensitivity testing for 5-FU and 5-FU derivatives using subrenal capsule assay].
Anai H; Maehara Y; Kusumoto H; Masuda H; Sugimachi K
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):635-8. PubMed ID: 3103537
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor and anticachectic activity of UFT in BALB/c mice bearing colon 26 adenocarcinoma].
Nukatsuka M; Fujioka A; Saito H; Nakano K; Uchida J; Oh-ie S; Nomura N; Takeda S; Unemi N; Ishitani K
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2013-20. PubMed ID: 8085852
[TBL] [Abstract][Full Text] [Related]
10. [Light and electron microscopic examination compared to evaluation by tumor size in subrenal capsule assay for chemosensitivity testing in esophageal cancer].
Akao S; Oya M; Ishikawa H; Kiumi F
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1813-9. PubMed ID: 7574815
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Ogata Y; Akagi Y; Nozoe Y; Sasatomi T; Miyagi Y; Nakagawa M; Matono K; Kobayashi H; Shirouzu K
Gan To Kagaku Ryoho; 2001 May; 28(5):655-60. PubMed ID: 11383214
[TBL] [Abstract][Full Text] [Related]
12. [Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice].
Basaki Y; Yonekura K; Chikahisa L; Okabe S; Hashimoto A; Miyadera K; Aoyagi K; Yamada Y
Gan To Kagaku Ryoho; 2000 Jan; 27(1):93-8. PubMed ID: 10660738
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of subrenal capsule assay (SRC) for clinical cancers].
Akao S; Iwami N; Oya M; Terada H; Sasaki K; Ishikawa H; Kiumi F
Gan To Kagaku Ryoho; 1996 Apr; 23(5):607-13. PubMed ID: 8678520
[TBL] [Abstract][Full Text] [Related]
14. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
[TBL] [Abstract][Full Text] [Related]
15. [Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay].
Nishiyama M; Takagami S; Kirihara Y; Saeki T; Niimi K; Kim R; Jinushi K; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2285-90. PubMed ID: 3136700
[TBL] [Abstract][Full Text] [Related]
16. [Subrenal capsule assay for chemosensitivity testing].
Kusuyama T; Fujita M; Shimozuma K; Orikasa H; Usugane M; Taguchi T
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1143-9. PubMed ID: 3105468
[TBL] [Abstract][Full Text] [Related]
17. Dipyridamole augments the antitumor effects of fluorinated pyrimidines.
Sakaguchi Y; Kusumoto T; Kusumoto H; Maehara Y; Furusawa M; Sugimachi K
Anticancer Res; 1992; 12(1):119-21. PubMed ID: 1567156
[TBL] [Abstract][Full Text] [Related]
18. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
Nakashima T; Miyagi M; Kusumoto T
Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
[TBL] [Abstract][Full Text] [Related]
19. [A six-day subrenal capsule assay for predictive testing of primary human tumors].
Yokoyama E; Irimajiri N; Shirakabe M; Matsumoto M; Haneda J; Kusunoki T; Utsunomiya J
Gan To Kagaku Ryoho; 1988 Jan; 15(1):67-71. PubMed ID: 3337530
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
